TWD 94.2
(-1.98%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 87.25 Million TWD | -8.99% |
2022 | 95.86 Million TWD | 15.64% |
2021 | 82.9 Million TWD | 80.6% |
2020 | 45.9 Million TWD | 39.34% |
2019 | 32.94 Million TWD | -21.12% |
2018 | 41.76 Million TWD | 27.35% |
2017 | 32.79 Million TWD | -4.51% |
2016 | 34.34 Million TWD | -29.89% |
2015 | 48.99 Million TWD | -24.5% |
2014 | 64.89 Million TWD | -10.51% |
2013 | 72.51 Million TWD | 55.68% |
2012 | 46.58 Million TWD | 72.68% |
2011 | 26.97 Million TWD | 147.24% |
2010 | 10.91 Million TWD | 41.3% |
2009 | 7.72 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 92.77 Million TWD | 6.33% |
2024 Q2 | 82.59 Million TWD | -10.97% |
2023 Q4 | 87.25 Million TWD | -6.82% |
2023 Q3 | 93.63 Million TWD | -1.61% |
2023 FY | 87.25 Million TWD | -8.99% |
2023 Q1 | 97.34 Million TWD | 1.54% |
2023 Q2 | 95.16 Million TWD | -2.24% |
2022 FY | 95.86 Million TWD | 15.64% |
2022 Q4 | 95.86 Million TWD | -1.68% |
2022 Q3 | 97.5 Million TWD | 14.57% |
2022 Q2 | 85.11 Million TWD | 5.41% |
2022 Q1 | 80.74 Million TWD | -2.6% |
2021 FY | 82.9 Million TWD | 80.6% |
2021 Q2 | 52.79 Million TWD | 24.21% |
2021 Q4 | 82.9 Million TWD | 22.65% |
2021 Q1 | 42.5 Million TWD | -7.4% |
2021 Q3 | 67.59 Million TWD | 28.02% |
2020 Q3 | 41.55 Million TWD | 33.6% |
2020 FY | 45.9 Million TWD | 39.34% |
2020 Q4 | 45.9 Million TWD | 10.46% |
2020 Q1 | 29.08 Million TWD | -11.72% |
2020 Q2 | 31.1 Million TWD | 6.96% |
2019 Q4 | 32.94 Million TWD | -9.22% |
2019 Q1 | 38.34 Million TWD | -8.19% |
2019 FY | 32.94 Million TWD | -21.12% |
2019 Q3 | 36.28 Million TWD | 10.82% |
2019 Q2 | 32.74 Million TWD | -14.6% |
2018 Q2 | 34.16 Million TWD | 21.32% |
2018 Q1 | 28.16 Million TWD | -14.13% |
2018 FY | 41.76 Million TWD | 27.35% |
2018 Q4 | 41.76 Million TWD | 13.57% |
2018 Q3 | 36.77 Million TWD | 7.64% |
2017 Q1 | 43.03 Million TWD | 25.3% |
2017 Q3 | 35.65 Million TWD | -10.79% |
2017 Q4 | 32.79 Million TWD | -8.01% |
2017 FY | 32.79 Million TWD | -4.51% |
2017 Q2 | 39.96 Million TWD | -7.13% |
2016 Q2 | 36.89 Million TWD | -17.25% |
2016 Q1 | 44.58 Million TWD | -9.0% |
2016 FY | 34.34 Million TWD | -29.89% |
2016 Q3 | 36.9 Million TWD | 0.02% |
2016 Q4 | 34.34 Million TWD | -6.92% |
2015 Q4 | 48.99 Million TWD | -6.65% |
2015 FY | 48.99 Million TWD | -24.5% |
2015 Q3 | 52.48 Million TWD | -9.78% |
2015 Q2 | 58.17 Million TWD | -1.93% |
2015 Q1 | 59.31 Million TWD | -8.59% |
2014 Q3 | 64.31 Million TWD | -10.45% |
2014 Q2 | 71.81 Million TWD | -2.66% |
2014 Q1 | 73.78 Million TWD | 1.75% |
2014 FY | 64.89 Million TWD | -10.51% |
2014 Q4 | 64.89 Million TWD | 0.9% |
2013 Q4 | 72.51 Million TWD | -3.57% |
2013 Q1 | 53.55 Million TWD | 14.98% |
2013 FY | 72.51 Million TWD | 55.68% |
2013 Q3 | 75.19 Million TWD | 28.13% |
2013 Q2 | 58.69 Million TWD | 9.58% |
2012 FY | 46.58 Million TWD | 72.68% |
2012 Q3 | 43.55 Million TWD | 19.81% |
2012 Q2 | 36.35 Million TWD | 0.0% |
2012 Q4 | 46.58 Million TWD | 6.95% |
2011 Q4 | 26.97 Million TWD | 0.0% |
2011 Q2 | 20.08 Million TWD | 0.0% |
2011 FY | 26.97 Million TWD | 147.24% |
2010 Q4 | 10.91 Million TWD | 0.0% |
2010 FY | 10.91 Million TWD | 41.3% |
2009 FY | 7.72 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 705.32 Million TWD | 87.629% |
Maxigen Biotech Inc. | 85.18 Million TWD | -2.426% |
Bionime Corporation | 491.25 Million TWD | 82.239% |
Pegavision Corporation | 583.47 Million TWD | 85.046% |
Visco Vision Inc. | 606.06 Million TWD | 85.604% |